Immediately downstream of RAFs, MEK is one of the main signaling nodes in the MAPK pathway and MEK inhibitors have shown significant growth inhibitory effects in some BRAF and NRAS mutant melanoma cells [12,13]. Here, NRAS is linked to melanoma.